AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Agentix Corp.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.02+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $801.34K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Agentix has not reported a dividend
No dividend per share appears in Agentix's annual filings since fiscal 2013.